CenExel Clinical Research | Anaheim Clinical Trials

Research site

(Unclaimed)

Location

2441 W La Palma Avenue,  Suite 140, Anaheim, California, United States of America

Site insights

Top conditions

Top treatments

Risankizumab

VX-548

PF-06882961

PF-06700841

LY3502970

PF-06291874

PF-07081532

Acetaminophen

Rosuvastatin

Midazolam

Parent organization

This site is a part of CenExel Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

20 of 218 total trials

A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity

The purpose of this study is to evaluate how well eloralintide and eloralintide with tirzepatide is tolerated and what side effects may occur in part...

Not yet enrolling

Overweight

Obesity

Drug: Eloralintide and Tirzepatide

Drug: Eloralintide

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Enrolling

Type 2 Diabetes Mellitus (T2DM)

Drug: Maridebart Cafraglutide

Drug: Placebo

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting

COVID-19

Biological: mRNA-1283.222

Biological: mRNA-1273.815

A Study of Oral YUQ-A1007 in Healthy Volunteers

YUQ-A1007 is a novel gut-enriched AhR agonist. The nonclinical pharmacology study indicated that YUQ-A1007 has the potential to treat IBD.YUQ-A1007 h...

Enrolling

Healthy

Drug: YUQ-A1007 is a novel gut-enriched AhR agonist. This compound is undergoing preclinical development, and comprehensive nonclinical studies.

A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participa...

Active, not recruiting

Celiac Disease

Drug: Cohort 2 in Part A

Drug: Group 4 in Part B and Part C

A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Xanomeline With Trospium Chloride Versus KarXT in Healthy Adult and Elderly Participants of Japanese Ethnicity and to Assess the Effect of Omeprazole on the PK of Xanomeline With Trospium Chloride in Healthy Adult Participants

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics (PK) of multiple doses of KarXT + KarX-EC capsules versus KarXT...

Enrolling

Healthy Volunteers

Drug: Placebo

Drug: Omeprazole

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

The main purpose of this study is to see how much of orforglipron (study drug) gets into the bloodstream and how long it takes the body to get rid of...

Active, not recruiting

Overweight

Obese

Drug: Orforglipron

New

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954

The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of multiple doses of VIS954 compared with placebo in heal...

Enrolling

Healthy

Drug: VIS954

Drug: Placebo

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...

Enrolling

COVID-19 (Coronavirus Disease 2019)

Influenza

Biological: Licensed Influenza Vaccine 1

Biological: Investigational Influenza Vaccine

Locations recently updated

A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

The purpose of the study is to learn how the study medicine called PF-07868489 is tolerated and acts in healthy adult people and people with pulmonar...

Enrolling

Pulmonary Arterial Hypertension

Drug: Placebo for PF-07868489

Drug: PF-07868489

A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple escalating oral doses o...

Active, not recruiting

Type 2 Diabetes Mellitus (T2DM)

Obesity

Drug: Rosuvastatin

Drug: Omeprazole

A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

The purpose of this study is to learn the following about the study medicine, danuglipron, after multiple days of dosing in healthy adults who are ov...

Active, not recruiting

Obesity

Drug: Rosuvastatin

Drug: Atorvastatin

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss and Fat Loss (COURAGE)

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting

Obesity

Drug: Matching Placebo-Trevogrumab

Drug: Matching Placebo-Garetosmab

Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty (DMT2111)

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Enrolling

Pain, Postoperative

Drug: Placebo Patch

Drug: DMTS Patch

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of escalating single and repeat doses of PF-07832837 in health...

Enrolling

Atopic Dermatitis

Healthy Participants

Other: Placebo

Drug: PF-07832837

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare th...

Active, not recruiting

Gout

Other: Placebo

Drug: Allopurinol

Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. The...

Enrolling

Healthy

Biological: V540B

Biological: GARDASIL®9 (G9)

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.

Active, not recruiting

Cardiometabolic Disease

Drug: Placebo

Drug: AMG 513

Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity

The purpose of this study is to see how two study medicines, PF-07976016 and danuglipron, taken together affect the level of each other in the blood...

Enrolling

Overweight

Obesity

Drug: PF-06882961

Drug: PF-07976016

To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults

An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody response of a vaccine to prevent s...

Active, not recruiting

Clostridoides Difficile Associated Disease

Biological: C. difficile vaccine formulation 1.

Other: Saline Placebo.